Vlado Perkovic's Publications

• IL-6 Inhibitor Ziltivekimab Increases Serum Hemoglobin and Iron Biomarkers in Patients with CKD Stage 3-5: A RESCUE Trial Analysis

  Journal articles

  2021

  Journal of the American Society of Nephrology

• Circulating Metabolites to Predict Renal Outcomes in CANVAS Type 2 Diabetes Mellitus Population

  Journal articles

  2021

  Journal of the American Society of Nephrology

• Corrigendum

  Journal articles

  2021

  ESC Heart Failure

• Canagliflozin Reduces All-cause Hospitalization in Patients with Type 2 Diabetes Mellitus

  Conference Abstracts

  2021

  Metabolism

• Higher-dose sitagliptin and the risk of congestive heart failure in older adults with CKD

  Journal articles

  2020

  Clinical Journal of the American Society of Nephrology

• Effects of canagliflozin in patients with baseline eGFR <30 mlmin per 1.73 msup2sup: Subgroup analysis of the randomized CREDENCE trial

  Journal articles

  2020

  Clinical Journal of the American Society of Nephrology

• Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: A post hoc analysis from the Credence trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• GLOMERULAR DISEASE REGISTRY AND BIOBANK (GRIT)

  Conference Abstracts

  2020

  NEPHROLOGY

• VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE

  Conference Abstracts

  2020

  NEPHROLOGY

• THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY

• THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL

  Conference Papers

  2020

  NEPHROLOGY

• THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY

• THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY

• THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY

• A randomized trial on the effect of phosphate reduction on vascular end points in CKD (improve-CKD)

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning

  Journal articles

  2020

  Journal of Cardiac Failure

• Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial

  Journal articles

  2020

  The Lancet Diabetes and Endocrinology

• Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program

  Journal articles

  2020

  Diabetes, Obesity and Metabolism

• The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program

  Journal articles

  2020

  International Journal of Cardiology

• Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories: Post hoc analysis of a randomized, double-blind, placebo-controlled, multinational trial

  Journal articles

  2020

  Clinical Journal of the American Society of Nephrology

• Different eGFR decline thresholds and renal effects of canagliflozin: Data from the CANVAS program

  Journal articles

  2020

  Journal of the American Society of Nephrology

• International consensus definitions of clinical trial outcomes for kidney failure: 2020

  Journal articles

  2020

  Kidney International

• The impact of the COVID-19 pandemic on medical education

  Journal articles

  2020

  Medical Journal of Australia

• No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial

  Journal articles

  2020

  Nephrology

• Haemodialysis duration, frequency and intensity for end-stage kidney disease

  Journal articles

  2020

  Cochrane Database of Systematic Reviews

• Effects of canagliflozin on cardiovascular death and hospitalisation for heart failure by eGFR: integrated analyses of the CANVAS Program and CREDENCE

  Conference Abstracts

  2020

  DIABETOLOGIA